N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development

• Κύριοι συγγραφείς: Yi Niu (Συγγραφέας), Arabella Wan (Συγγραφέας), Ziyou Lin (Συγγραφέας), Xiongbin Lu (Συγγραφέας), Guohui Wan (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2018-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

N6-Methyladenosine (m6A) modification is the most pervasive modification of human mRNA molecules. It is reversible via regulation of m6A modification methyltransferase, demethylase and proteins that preferentially recognize m6A modification as "writers", "erasers" and "reade...